IACH Webinars
Webinar Video Library
High-Quality Peer Review: a Few Tips
Mohamad Mohty
December 2, 2024
Blood Diseases in the ICU
Elie Azoulay
November 28, 2024
Management of Waldenstrom disease: an update
Jorge Castillo
November 21, 2024
Myélome multiple: traitements de la rechute hors immunothérapie (French)
Jean-Marc Schiano De Colella, Arthur Bobin
November 18, 2024
Social Media in Medicine: a few tips on how to manage your virtual reputation
Mohamad Mohty
November 12, 2024
CAR-T cells for AML: Where Do We Stand?
Sébastien Anguille
October 23, 2024
How to Get Published: a Few Tips
Mohamad Mohty
October 17, 2024
Delivering an Impactful Presentation: a Few Tips
Mohamad Mohty
October 9, 2024
CD47: From the Bench to the Bedside?
Joshua Fein
September 26, 2024
Transplant Indications in Non-Hodgkin Lymphoma: Where Do We Stand?
Ali Bazarbachi
September 11, 2024
The Emerging Role of the Immune Microenvironment in Hematological Malignancies
Katia Beider
July 16, 2024
Hottest Myeloma Topics: Disease Outcome, MRD, Mass Spectrometry and Beyond – An IACH Round Table Discussion
Faith Davies, Hans Jacobs, Ola Landgren, Mohamad Mohty
June 27, 2024
How do I Assess Frailty Prior to Stem Cell Transplantation?
Munshi Pashna
June 3, 2024
TMA and Stem Cell Transplantation: From Diagnosis to Therapy
Sumithira Vasu
May 29, 2024
Sickle Cell Disease Landscape and Challenges
Mariane De Montalembert
May 28, 2024
State of the Art Management of Follicular Lymphoma
Nilanjan Ghosh
May 16, 2024
Allogeneic Stem Cell Transplantation for Myelofibrosis
Ibrahim Yakoub-Agha
May 7, 2024
Curative Therapies for Transfusion Dependent Thalassaemia
Josu de la Fuente
May 6, 2024
Maintenance therapy after Allogeneic stem cell transplantation for Flt3-ITD AML: current status and guidelines
Ali Bazarbachi
April 29, 2024
DLI after allogeneic stem cell transplantation: where do we stand?
Panagiotis Tsirigotis
April 25, 2024
Influenza Vaccines and Therapy in Allogeneic Hematopoietic Cell Transplant Recipients
Natasha Halasa
March 28, 2024
Academic CAR-T Therapy: Learnings from the Indian Subcontinent
Hasmukh Jain
February 29, 2024
Pathology Made Easy for the Clinical Hematologist
Sanam Loghavi
February 21, 2024
Diagnosis and management of systemic mastocytosis: what’s new in 2024?
Prithviraj Bose
February 14, 2024
Aplastic anemia management: what’s new?
Baldeep Wirk
February 13, 2024
Vaccination against COVID-19: Where do we stand?
Eolia Brissot
February 7, 2024
Management of Chronic Myeloid Leukemia (CML) in special populations
Mhairi Copland
January 25, 2024
Management of AL amyloidosis: an update
Hasib Sidiqi
January 10, 2024
Affinities Between Wine and Hematopoietic Stem Cell Transplantation
Shaun Mccann
January 4, 2024
Regulatory T cells in hematology: Where do we stand?
Alexandros Spyridonidis
December 7, 2023
Live from ASH23 take home message
Ali Bazarbachi, Mohamed Kharfan Dabaja, Florent Malard, Salomon Manier, Arnon Nagler, Amer Zedain
December 12, 2023
Management of High-Risk Chronic Lymphocytic Leukemia
Anne Quinquenel
December 5, 2023
PNH: New Therapeutic Update
Jeff Szer
November 30, 2023
Is it possible to Provide the Art of Personalized Cell Therapy in the Era of Increasing Computer Driven Care?
Finn Bo Petersen
October 26, 2023
HTLV-related malignancies: Where do we stand?
Shigeo Fuji
September 28, 2023
Clonal Hematopoiesis: Origins and Clinical Implications
Lourdes Mendez
August 1, 2023
Treatment of Acute Lymphoblastic Leukemia, with a Special Focus on the Role of Asparaginase and Conventional Chemotherapy
André Baruchel, Nicolas Boissel, Jose-Maria Ribera, Kjeld Schmiegelow, Inge Van Der Sluis, Mohamad Mohty
July 4, 2023
A Focus on Small Molecules in Myeloma
Lisa Leypoldt, Elias Mai, Maximilian Merz, Mohamad Mohty
July 3, 2023
Management of Refractory Anemia in Myeloid Malignancies
Matteo Della Porta
June 26, 2023
Management of Waldenstrom Macroglobulinemia: an update
Monique Minnema
May 24, 2023
Optimising transplant outcome in adults allografted for AML
Charles Craddock
May 3, 2023
Allogeneic stem cell transplantation for older patients: where do we stand?
Didier Blaise
April 18, 2023
Non alcoholic fatty liver disease: a global health challenge not sparing hematology
Pierre Brissot
March 29, 2023
Management of chronic myeloid leukemia: an update
De Lavallade Hugues
March 15, 2023
Post-TCT Review: Transplant and Cellular Therapy (Part 2)
Dr. Bipin Savani
March 28, 2023
Post-TCT Review: Transplant and Cellular Therapy (part 1)
Bipin Savani
March 14, 2023
Telemedicine in hematology: where do we stand?
Malte Jacobsen, Alberto Mussetti, Jonas Paludo
March 7, 2023
Current and Future Haemophilia Treatments
Michael Makris
Feb. 28, 2023
Bi-and tri-specific antibodies in non-Hodgkin Lymphoma: current data and perspectives
Clémentine Sarkozy
January 19, 2023
Telemedicine in hematology: where do we stand?
Malte Jacobsen, Alberto Mussetti, Jonas Paludo
March 7, 2023
Current and Future Haemophilia Treatments
Michael Makris
Feb. 28, 2023
Bi-and tri-specific antibodies in non-Hodgkin Lymphoma: current data and perspectives
Clémentine Sarkozy
January 19, 2023
Bench at Bedside Models Facilitate CAR-T Cell Supply Chain
Folashade Otegbeye
January 3, 2023
Gene therapy in hemoglobinopathies
Haydar Frangoul
December 20, 2022
ITP: novel treatments
James B Bussel
December 5, 2022
Bispecific antibodies in lymphoma: an update
Mazyar Shadman
November 29, 2022
Diagnostic and therapy of Ph-like acute lymphoblastic leukemia
Ibrahim Aldoss
November 7, 2022
Management of T-ALL: an update
Huang Xiao Jun
November 2, 2022
IDH inhibitors in relapsed/refractory AML
Pau Montesinos Fernandez
October 19, 2022
Machine learning and artificial intelligence in Hematology
Roni Shouval
October 3, 2022
Management of patients with Fanconi Anemia
Carmem Bonfim
June 30, 2022
CAR-T Cells in Lymphoma: the latest data
Roch Houot
May 19, 2022
GVHD in 2022: from prevention to therapy
Bipin Savani
April 12, 2022
Updates in Chronic Graft-versus-Host Disease (GVHD) Management
Catherine J. Lee
Mar. 24, 2022
Immune-based approaches in AML
Naval Daver
Dec. 8, 2021
Targeted Therapies in AML
Naval Daver
Dec. 7, 2021
Alkylating agents: old dogs with new tricks
Didier Blaise, Remy Dulery, Arnon Nagler, Mohamad Mohty
Nov. 15, 2021
Systemic Mastocytosis
Celalettin Ustun
Nov. 4, 2021
Management of CLL in 2021 and Beyond
Nitin Jain
Oct. 19, 2021
Novel Therapeutic Approaches in BPDCN : Targeting CD123 and Beyond
Naveen Pemmaraju
Sept. 30, 2021
HTLV-1 associated malignancies: from diagnosis to treatment
Ali Bazarbachi
Sept. 16, 2021
CAR T-cells in lymphoma: new advances and practical aspects
Dr. Rémy Duléry
July 22, 2021
The Therapeutic Revolution in management of Higher risk MDS: A focus on immunotherapy
Prof. Amer Zeidan
Management of leukemia and stem cell transplant patients during the COVID-19 pandemic
Prof. Bipin Savani
May 26, 2021
Latest advances in the management of Hodgkin lymphoma
Dr. Remy Dulery
Hemochromatosis: what’s important and new in 2020?
Prof. Pierre Brissot
Post-Transplant Complications: A Focus on Veno-Occlusive Disease (VOD)
Prof. Mohamad Mohty
TPO agents beyond ITP: aplastic anemia, inherited thrombocytopenia and chemotherapy induced thrombocytopenia
Prof. James Bussel
Current perspectives on management of AL amyloidosis
Eli Muchtar, M.D
Cold Agglutinin Disease Laboratory Evaluation and Treatment Options
Garrett S. Booth, M.D.
Therapeutic options for sickle cell disease in 2019
Prof. Selim Corbacioglu
Management of relapsed DLBCL in era of CAR-T therapy
Dr. Veronika Bachanova
What should you know on what is new in aplastic anemia
Prof. Phillip Scheinberg
MPN – Whom to transplant, when and how
Prof. H. Joachim Deeg
Indications for allogeneic stem cell transplantation in AML
Arnon Nagler, M.D., M.Sc
Measurable Residual Disease in Acute Myeloid Leukemia (MRD in AML)
Prof. Christopher S. Hourigan DM DPhil FACP FRCP
Host-microbiome symbiosis in health and disease
Dr. Joël Doré
Nutritional supplements and complementary/alternative medical practices in patients with hematologic diseases
Prof. Bipin N. Savani
CD19 CAR T cells in lymphoid malignancies – 2018 Update
Miguel-Angel Perales, MD
Therapy of relapsed multiple myeloma – An update
Mohamad Mohty, MD, PhD
IACH Webinars dedicated to the COVID-19 pandemic
The COVID-19 pandemic emergency and young physicians: life before and after the crisis?
Carolina Marini, Mohamad Mohty
The COVID-19 pandemic emergency and hematology: reporting live from the ICU
Giovanni Landoni, Mohamad Mohty
The COVID-19 pandemic emergency and management of acute leukemia: challenges and options
Naveen Pemmaraju, Mohamad Mohty
The COVID 19 pandemic emergency and hematology a psychologist perspective
Yolande Arnault, Mohamad Mohty
The COVID-19 pandemic emergency and the ethics of research
Philippe Gabriel Steg, Mohamad Mohty
A COVID-19 personal experience: when a hematologist becomes a patient as well as caregiver
Noopur Raje, Mohamad Mohty
The COVID-19 pandemic emergency and hematology: experience and perspectives from Italy
Mohamad Mohty, Annalisa Ruggeri
Management of multiple myeloma during COVID 19
Prof. Mohty, Prof. Mateos
COVID-19 and hematological malignancies: a few practical issues
Prof. Mohty, Prof. Chabannon
CAR-T cells in lymphoid diseases: A web-conference by the IACH (April 4, 2020)
Results in adult ALL
Prof. Jordan Gauthier
Results in lymphoma
Prof. Saad Kenderian
Results in myeloma
Prof. Mohamad Mohty